Covid-19 forces biggest HIV conference to go virtual for the first time
1 Mins read
Reading Time: < 1 minute Around this time of the year every two years the HIV community gathers in droves in a huge international convention centre somewhere in…
HIV, COVID-19 and the importance of public health
1 Mins read
Reading Time: < 1 minute As COVID-19 cases continue to rise — it is a sobering moment to recognize and take stock of another epidemic that we…
'Don't give up hope' in fighting viruses, says 'cured' London AIDS patient
1 Mins read
Reading Time: < 1 minute A previously HIV-positive man who is only the second known adult worldwide to be “functionally cured” of HIV called on Friday Read…
34 new HIV cases detected in six months
1 Mins read
Reading Time: < 1 minute Heterosexual act or sexual intercourse with an opposite sex is the common mode of transmission among the 34 new Human Immunodeficiency Virus (HIV)…
Perthshire councillor slammed for likening the transmission of coronavirus to that of HIV
1 Mins read
Reading Time: < 1 minute David Illingworth made the comment in a tweet while debating the question of closing the border between Scotland and England Read More
India's HIV and TB patients suffer consequences of coronavirus pandemic
1 Mins read
Reading Time: < 1 minute When the coronavirus pandemic hit India, many were worried that the country’s overworked public healthcare system Read More
U.S. FDA approves GSK's HIV drug for patients with limited options
1 Mins read
Reading Time: < 1 minute The U.S. Food and Drug Administration on Thursday approved GlaxoSmithKline Plc’s HIV drug, Rukobia, to treat adult patients, Read More
New Data Shows Promise Involving Lenacapavir for the Treatment of HIV
1 Mins read
Reading Time: < 1 minute A study published in the journal Nature on July 1 suggests that there may be a new way to target an HIV…
Not adhering to ARVS among adolescents could fuel new infections - study
1 Mins read
Reading Time: < 1 minute Adolescents in Uganda living with HIV risk becoming critically ill or dying because they fear to disclose their status. Read More
GSK says it is within weeks of resubmitting HIV injection Cabenuva
1 Mins read
Reading Time: < 1 minute GlaxoSmithKline’s HIV business ViiV is within weeks of resubmitting its request for approval of its long-acting injection Cabenuva Read More